Marilena Vrana: Building Momentum for the Future of Plasma-Derived Therapies
Marilena Vrana, Vice President of Public Affairs and EU Operations at Plasma Protein Therapeutics Association (PPTA), shared a post on LinkedIn:
” ‘Energizing’ is the word that best describes the recently concluded Plasma Protein Forum in Alexandria, Va. Two intense and impactful days focused on strengthening the future of plasma-derived medicines through greater awareness, access and availability. The moving patient and donor stories paint the path forward.
Thank you to all the sponsors, speakers, panelists, and attendees from across the global plasma community for helping to make the event a success.
The sessions emphasized how much this industry has accomplished and yet how much remains to be done to ensure all patients who need lifesaving plasma-derived medicines have access to them.
While in the U.S., I also visited my first U.S. plasma donation center, in Maryland – thank you BioLife Plasma Services. It put the exclamation point on the importance of Plasma Protein Therapeutics Association (PPTA) mission. It was amazing to see generous donors supporting patients around the world, and a dedicated and informed staff who were committed to caring for donors to ensure patient health down the line.
I return to Brussels with plenty of insightful takeaways that will accelerate PPTA Europe’s work on behalf of patients across Europe. Despite rising challenges, our focus is as clear as ever.
Let’s work together to seize the momentum and run with it.”

Stay updated with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery